ARCHIVES

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Harold Varmus Plans To Leave Presidency Of MSKCC

January 15, 2010

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009